Prescription Drugs in the US Must Be Viewed as Critical Infrastructure | ASPL 2024
Drug Topics
NOVEMBER 9, 2024
Stephen Schondelmeyer, PharmD, PhD, FAPhA, gave a presentation on US drug shortages and their global implications.
Drug Topics
NOVEMBER 9, 2024
Stephen Schondelmeyer, PharmD, PhD, FAPhA, gave a presentation on US drug shortages and their global implications.
Pharmacy Times
NOVEMBER 9, 2024
Reasons for supporting the lowering of the age-based pneumococcal vaccine recommendation included the likelihood it would increase vaccination rates in multiple age groups and demographics.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Guardian - Pharmaceutical Industry
NOVEMBER 9, 2024
As UK diagnoses have doubled, prescriptions of the treatment have halved. While experts feud over its use, many patients feel it is an effective way of managing their condition Occupational stress is a trigger for Rebecca Wilde, a 32-year-old tech worker in Buckinghamshire. Four years ago, work pressures combined with family issues affected her sleep, leading to a severe manic episode.
Pharmacy Times
NOVEMBER 9, 2024
Pharmacists should be aware of current discussions, attempted fixes, and expected length of drug shortages.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Fierce Healthcare
NOVEMBER 9, 2024
Women’s health providers are reporting a major surge in emergency contraception, birth control and medication abortion sales since the election last week. | Though women's health providers also saw a jump in sales following the overturning of Roe v. Wade, many say the latest surge exceeds previous numbers.
STAT
NOVEMBER 9, 2024
Biotech analyst Brian Skorney and longtime biotech executive Daphne Zohar joined this week’s episode of “The Readout LOUD” to discuss how a new Trump administration may affect the Food and Drug Administration, the biotech industry, and stocks. Below are highlights from their conversation with hosts Elaine Chen, Adam Feuerstein, and Allison DeAngelis.
Let's personalize your content